Journal article


Gail MacKean, Tom Noseworthy, Adam G Elshaug, Laura Leggett, Peter Littlejohns, Joan Berezanski, Fiona Clement

International Journal of Technology Assessment in Health Care | CAMBRIDGE UNIV PRESS | Published : 2013


BACKGROUND: Health technology reassessment (HTR) is "a structured, evidence-based assessment of the clinical, social, ethical, and economic effects of a technology currently used in the healthcare system, to inform optimal use of that technology in comparison to its alternatives." The purpose of this study is to describe the key themes in the context of current HTR activities and propose a way forward for this newly emerging field. METHODS: Data were gathered from a workshop held as part of the 2012 Canadian Agency for Drugs and Technology in Health (CADTH) symposium. The workshop consisted of two panel presentations followed by discussion; data gathered, including presentations and rich aud..

View full abstract


Funding Acknowledgements

The workshop was supported by the Canadian Agency for Drugs and Technology in Health (CADTH). The views presented herein present the views of the authors and not necessarily CADTH or The Commonwealth Fund. Dr. Elshaug is the NHMRC Sidney Sax Fellow (ID 627061) at the University of Adelaide, Australia and at Harvard Medical School, Boston, and the Inaugural Visiting Fellow of the Commonwealth Fund in New York.